This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don't share our data with other parties. Which cookies are involved?

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Which cookies are involved?

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.

Back to overview

Marjanka Schmidt group

MarkankjaSchmidt.jpg

Marjanka Schmidt

Groupleader

Personal details

Experience

Marjanka Schmidt was awarded a Translational Cancer Research Award from the Dutch Cancer Society in 2009 to start her own research line. Her research line focuses on the effects of genetic variants on risk of breast cancer subtypes, prognosis and long-term outcome of breast cancer, combining the areas of epidemiological and molecular research. One major promise is that advances in the genetics area will lead to personalized medicine, where preventive and therapeutic interventions for complex diseases can be individually tailored to a person's genetic profile. Marjanka's group aims to contribute to the genome-based applications in health care practice by elucidating the role of germline variants in breast cancer risk and prognosis by molecular and genetic epidemiological studies, as well as addressing ethical, legal and societal aspects of genomics.

Share this page